Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 113

1.

Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis.

Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI.

BMJ. 2012 Aug 7;345:e4944. doi: 10.1136/bmj.e4944. Review.

PMID:
22872710
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Steroidal contraceptives and bone fractures in women: evidence from observational studies.

Lopez LM, Chen M, Mullins S, Curtis KM, Helmerhorst FM.

Cochrane Database Syst Rev. 2012 Aug 15;8:CD009849. doi: 10.1002/14651858.CD009849.pub2. Review.

PMID:
22895991
[PubMed - indexed for MEDLINE]
3.

Combined hormonal versus nonhormonal versus progestin-only contraception in lactation.

Truitt ST, Fraser AB, Grimes DA, Gallo MF, Schulz KF.

Cochrane Database Syst Rev. 2003;(2):CD003988. Review.

PMID:
12804497
[PubMed - indexed for MEDLINE]
4.

Hormonally impregnated intrauterine systems (IUSs) versus other forms of reversible contraceptives as effective methods of preventing pregnancy.

French R, Van Vliet H, Cowan F, Mansour D, Morris S, Hughes D, Robinson A, Proctor T, Summerbell C, Logan S, Helmerhorst F, Guillebaud J.

Cochrane Database Syst Rev. 2004;(3):CD001776. Review.

PMID:
15266453
[PubMed - indexed for MEDLINE]
5.

Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10.

Lidegaard O, Nielsen LH, Skovlund CW, Løkkegaard E.

BMJ. 2012 May 10;344:e2990. doi: 10.1136/bmj.e2990.

PMID:
22577198
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Hormonal versus non-hormonal contraceptives in women with diabetes mellitus type 1 and 2.

Visser J, Snel M, Van Vliet HA.

Cochrane Database Syst Rev. 2006 Oct 18;(4):CD003990. Review. Update in: Cochrane Database Syst Rev. 2013;3:CD003990.

PMID:
17054193
[PubMed - indexed for MEDLINE]
7.

Hormonal contraception in women at risk of vascular and metabolic disorders: guidelines of the French Society of Endocrinology.

Gourdy P, Bachelot A, Catteau-Jonard S, Chabbert-Buffet N, Christin-Maître S, Conard J, Fredenrich A, Gompel A, Lamiche-Lorenzini F, Moreau C, Plu-Bureau G, Vambergue A, Vergès B, Kerlan V.

Ann Endocrinol (Paris). 2012 Nov;73(5):469-87. doi: 10.1016/j.ando.2012.09.001. Epub 2012 Oct 15.

PMID:
23078975
[PubMed - indexed for MEDLINE]
8.

Copper containing intra-uterine devices versus depot progestogens for contraception.

Hofmeyr GJ, Singata M, Lawrie TA.

Cochrane Database Syst Rev. 2010 Jun 16;(6):CD007043. doi: 10.1002/14651858.CD007043.pub2. Review.

PMID:
20556773
[PubMed - indexed for MEDLINE]
9.

Risk of venous thromboembolism from use of oral contraceptives containing different progestogens and oestrogen doses: Danish cohort study, 2001-9.

Lidegaard Ø, Nielsen LH, Skovlund CW, Skjeldestad FE, Løkkegaard E.

BMJ. 2011 Oct 25;343:d6423. doi: 10.1136/bmj.d6423.

PMID:
22027398
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cancer and contraception. Release date May 2012. SFP Guideline #20121.

Patel A, Schwarz EB; Society of Family Planning.

Contraception. 2012 Sep;86(3):191-8. doi: 10.1016/j.contraception.2012.05.008. Epub 2012 Jun 7.

PMID:
22682881
[PubMed - indexed for MEDLINE]
11.

Smoking and use of oral contraceptives: impact on thrombotic diseases.

Lidegaard O.

Am J Obstet Gynecol. 1999 Jun;180(6 Pt 2):S357-63.

PMID:
10368521
[PubMed - indexed for MEDLINE]
12.

Hormonal contraception and pelvic girdle pain during pregnancy: a population study of 91,721 pregnancies in the Norwegian Mother and Child Cohort.

Bjelland EK, Kristiansson P, Nordeng H, Vangen S, Eberhard-Gran M.

Hum Reprod. 2013 Nov;28(11):3134-40. doi: 10.1093/humrep/det301. Epub 2013 Jul 25.

PMID:
23887071
[PubMed - indexed for MEDLINE]
13.

Postmenopausal hormone replacement therapy: scientific review.

Nelson HD, Humphrey LL, Nygren P, Teutsch SM, Allan JD.

JAMA. 2002 Aug 21;288(7):872-81. Review.

PMID:
12186605
[PubMed - indexed for MEDLINE]
14.

Risk of acute thromboembolic events with oral contraceptive use: a systematic review and meta-analysis.

Peragallo Urrutia R, Coeytaux RR, McBroom AJ, Gierisch JM, Havrilesky LJ, Moorman PG, Lowery WJ, Dinan M, Hasselblad V, Sanders GD, Myers ER.

Obstet Gynecol. 2013 Aug;122(2 Pt 1):380-9. doi: 10.1097/AOG.0b013e3182994c43. Review.

PMID:
23969809
[PubMed - indexed for MEDLINE]
15.

Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.

Canonico M, Plu-Bureau G, Lowe GD, Scarabin PY.

BMJ. 2008 May 31;336(7655):1227-31. doi: 10.1136/bmj.39555.441944.BE. Epub 2008 May 20. Review.

PMID:
18495631
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Effects of progestin-only long-acting contraception on metabolic markers in obese women.

Bender NM, Segall-Gutierrez P, Najera SO, Stanczyk FZ, Montoro M, Mishell DR Jr.

Contraception. 2013 Sep;88(3):418-25. doi: 10.1016/j.contraception.2012.12.007. Epub 2013 Jan 2.

PMID:
23410714
[PubMed - indexed for MEDLINE]
17.

SOGC clinical practice guideline. No. 252, December 2010. Oral contraceptives and the risk of venous thromboembolism: an update.

Reid R; Society of Obstetricians and Gynaecologists of Canada.

J Obstet Gynaecol Can. 2010 Dec;32(12):1192-204. English, French.

PMID:
21176332
[PubMed - indexed for MEDLINE]
18.

Comparison of metabolic and inflammatory outcomes in women who used oral contraceptives and the levonorgestrel-releasing intrauterine device in a general population.

Morin-Papunen L, Martikainen H, McCarthy MI, Franks S, Sovio U, Hartikainen AL, Ruokonen A, Leinonen M, Laitinen J, Järvelin MR, Pouta A.

Am J Obstet Gynecol. 2008 Nov;199(5):529.e1-529.e10. doi: 10.1016/j.ajog.2008.04.013. Epub 2008 Jun 4.

PMID:
18533124
[PubMed - indexed for MEDLINE]
19.

Hormonally impregnated intrauterine systems (IUSs), versus other forms of reversible contraceptives as effective methods of preventing pregnancy.

French R, Cowan F, Mansour D, Morris S, Hughes D, Robinson A, Proctor T, Summerbell C, Logan S, Guillebaud J.

Cochrane Database Syst Rev. 2001;(2):CD001776. Review. Update in: Cochrane Database Syst Rev. 2004;(3):CD001776.

PMID:
11406007
[PubMed - indexed for MEDLINE]
20.

Exogenous progestins and breast cancer.

Stanford JL, Thomas DB.

Epidemiol Rev. 1993;15(1):98-107. Review.

PMID:
8405216
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk